Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease

Emerging Biologics in the Treatment of Inflammatory Bowel Disease: What is Around the Corner?

(2010) Gionata Fiorino et al.   CURRENT DRUG TARGETS

Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies

(2009) Eugene O. Major   Annual Review of Medicine

Anti-Adhesion Molecule Strategies for Crohn Disease

(2009) Yvette Leung et al.   BIODRUGS

The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease

(2009) Franco Scaldaferri et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

T1687 Infliximab Inhibits Mucosal Pathological Angiogenesis in Crohn's Disease

(2009) Silvio Danese et al.   GASTROENTEROLOGY

Immunotoxicity profile of natalizumab

(2009) Nancy G. Wehner et al.   Journal of Immunotoxicology

The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti- 4 7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases

(2009) D. Soler et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Anti-adhesion molecule therapies in inflammatory bowel disease: Touch and go

(2008) Tommaso Stefanelli et al.   AUTOIMMUNITY REVIEWS